Back to Search
Start Over
Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'.
- Source :
-
Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Oct; Vol. 80 (10), pp. e168. Date of Electronic Publication: 2021 May 07. - Publication Year :
- 2021
-
Abstract
- Competing Interests: Competing interests: MDC has received speaking fees from AbbVie and Novartis. FS has received speaking fees from Roche, AbbVie, Novartis, Bristol-Myers-Squibb, Pfizer and Merck Sharp and Dohme Italia. EF has received speaking fees from AbbVie, BMS, Janssen, Lilly, MSD, Novartis, Roche, Pfizer and UCB Pharma. WG has received speaking fees from AbbVie, Celgene, Grünenthal, Pfizer and UCB Pharma. All other authors disclose no conflict of interest.
Details
- Language :
- English
- ISSN :
- 1468-2060
- Volume :
- 80
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Annals of the rheumatic diseases
- Publication Type :
- Editorial & Opinion
- Accession number :
- 33962960
- Full Text :
- https://doi.org/10.1136/annrheumdis-2021-220586